Atlanta, GA, April 3, 2019 (Newswire.com) –
Florence, the company that advances clinical trials with software, welcomes healthcare IT industry veteran, Steve Chamberlain to its Advisory Network. Chamberlain, who also made an undisclosed investment in Florence, brings experience driving growth at disruptive companies including WebMD and Mana Health. “A business thrives based on the drive of the people behind it.” Says Chamberlain, “The team at Florence, including its Advisors, are making an impact on Clinical Research and therefore the pace of cures. I’m delighted to join them as their growth accelerates.”
Florence’s Advisory Network gathers innovative leaders who’ve changed how research gets done, with expertise spanning clinical research to technology. Chamberlain joins Carla Balch, CEO of TransMed systems, Cheryl Byers, Director at Moffit Cancer Center, Elena Jouravleva, Director of Clinical Operations at US Oncology Research, Casey Holland, Senior Director of Clinical Operations at Merit Medical, Carlos Orantes, CEO of Accel Clinical Research, and a host of others.
“This year will be challenging and productive for our Advisory Network,” notes Ryan Jones, Florence CEO. “Precision medicine is changing the array of therapies under study. As a result, research technologies, like Florence eBinders, eHub and eTMF, must help research teams manage through change. Our Advisory Network will help us build products aligned with our customers’ needs and allow us to grow to help thousands of more research teams in 2019.”
About Florence:
Florence advances clinical trials through software for managing document and data flow between research sites and sponsors. Florence eBinders™ is trusted by 4,000+ research teams to manage eRegulatory/eSource for over 1,000 studies; Florence eTMF is the most flexible eTMF on the market with a wide range of innovative features; and Florence eHub is revolutionizing site-sponsor connectivity for site oversight, monitoring, startup, and quality control.